Precision Bio (DTIL) Director Germano Buys 2,609 Shares

What Happened Germano Geno J, a director of Precision Biosciences, purchased 2,609 shares of the company's common stock in an open-market transaction on 2026-09-25. The shares were bought at $6.28 per share for a total cost of $16,385. This was a purchase (insider buying is often viewed as a potentially positive signal, while sales are frequently routine).

Key Details

• Transaction date: 2026-09-25; Price: $6.28 per share; Shares acquired: 2,609; Total value: $16,385. (Transaction code: P = Purchase, open market)
• Filing date: 2026-09-29 (the Form 4 was filed after the transaction; marked late).
• Shares owned after transaction: not specified in the provided filing data.
• No footnotes (e.g., 10b5-1 plan or tax withholding) were provided in the summary information supplied.

Context

• This was a straightforward open-market purchase by a company director. While the amount ($16k) is modest, director purchases can be of interest to investors as they indicate insiders increasing holdings.
• The late filing reduces timeliness of this disclosure for market participants; retail investors should consider filing timeliness when weighing insider activity.